A Review of Islamic Investment Literature
Economic Papers: A journal of applied economics and policy · 2019-12 · 38 (4) · 345-380
DOI: 10.1111/1759-3441.12230 ↗Kurz gefasst
Fachartikel in der Zeitschrift Economic Papers: A journal of applied economics and policy, online erschienen am 30.09.2018. Verfasst von M. Kabir Hassan und 3 weiteren Autor:innen. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 112 Literaturangaben.
Abstract (Originalsprache)
This paper reviews the empirical literature on the contemporary issues of Islamic investments and highlights the future research directions. The growing literature during the last several years and the penetration of Islamic investments beyond the Muslim majority countries motivate us to review the empirical studies in the area. We therefore focus our literature review on mutual funds, sukuk and equity investments, analysing 81 articles from the most important journals dealing with the topic. The mixed findings in this area help the understanding of professionals not familiar with Islamic investment to identify the trends of the literature for important decisions. Our results have also important financial implications for asset managers willing to include Islamic financial instruments into a well‐diversified portfolio.
Zitieren
APA
Hassan, M. K., Aliyu, S., Paltrinieri, A., & Khan, A. (2019). A Review of Islamic Investment Literature. Economic Papers: A journal of applied economics and policy, 38(4), 345-380. https://doi.org/10.1111/1759-3441.12230
Vancouver
Hassan MK, Aliyu S, Paltrinieri A, Khan A. A Review of Islamic Investment Literature. Economic Papers: A journal of applied economics and policy. 2019;38(4):345-380. doi:10.1111/1759-3441.12230
BibTeX
@article{Hassan2019,
author = {Hassan, M. Kabir and Aliyu, Sirajo and Paltrinieri, Andrea and Khan, Ashraf},
title = {A Review of Islamic Investment Literature},
journal = {Economic Papers: A journal of applied economics and policy},
year = {2019},
volume = {38},
number = {4},
pages = {345--380},
doi = {10.1111/1759-3441.12230}
}
EUVIMED